The COVID-19 epidemic has triggered an acute need to minimize the time that patients spend in medical facilities and to reduce physical contact between patients and providers. In response to this need, Gynuity Health Projects recently led the collaborative development of a sample protocol for providing medication abortion to selected patients without any routine facility-based tests either before or after treatment. The protocol includes recommendations for patient screening, Rh status evaluation and management, the treatment regimen, and follow-up without facility-based tests. We also provide guidance on counseling patients using this approach. The sample protocol along with a sample patient instruction sheet and an explanatory commentary has been published in Contraception.
This technical brief provides guidance on providing maternity services during the novel coronavirus pandemic.
Postcard: Mifepristone now available through the Inter-Agency Reproductive Health Kits!
Ipas and WomenCareGlobalThis postcard provides instructions for obtaining Inter-Agency RH Kits, information on why mifepristone is now available in the kits, and a summary of WHO dosing for medication-induced abortions.
Postcard: Creating a sustainable supply of manual vacuum aspiration instruments in humanitarian settings
Ipas and WomanCareGlobalThis postcard for humanitarian professionals provides an overview of manual vacuum aspiration (MVA) for safe abortion and instructions for how to obtain MVA equipment through Inter-Agency RH Kits.
This two-page material provides simple instructions for safely using abortion with pills and is intended as a resource for health providers to share with their patients.
This two-page material provides simple instructions for safely using abortion with pills and is intended as a resource for health providers to share with their patients.
Abortion pills in first 12 weeks since last period: mifepristone and misoprostol under the tongue
IpasThis two-page material provides simple instructions for safely using abortion with pills and is intended as a resource for health providers to share with their patients.
This two-page material provides simple instructions for safely using abortion with pills and is intended as a resource for health providers to share with their patients.
Contraceptive Use Among Adolescent and Young Women in North and South Kivu, Democratic Republic of the Congo: A Cross-sectional Population-Based Survey
Sara E. Casey, Meghan C. Gallagher, Jessica Kakesa, Anushka Kalyanpur, Jean-Baptiste Muselemu, Raoza Vololona Rafanoharana, Nathaly SpilotrosThis cross-sectional study analyzes contraceptive prevalence among sexually active adolescent girls and women (ages 15-24) in the areas of North and South Kivu in the Democratic Republic of Congo.
This factsheet calls for European donors to increase funds dedicated to sexual and reproductive health in emergency and humanitarian settings.
Sensitivity and Specificity of Placental Proteins for Gestational Age Screening: An Exploratory Study
Gynuity Health ProjectsThis study explores two types of serum found in pregnant women's urine, as it relates to identifying pregnancy via protein presence.
A Non-Inferiority Study of Outpatient Mifepristone-Misoprostol Medical Abortion at 64–70 Days and 71–77 Days of Gestation
Gynuity Health ProjectsThis non-inferiority study assessed efficacy of a common outpatient medical abortion regimen among people with pregnancies 64–70 days and 71–77 days of gestation.